Received Sep 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | 30525810 | IM |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) in a 43-year-old male patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) (batch no. 30525810) for COVID-19 prophylaxis. Co-suspect product included non-company product Influenza vaccine (Flu) for an unknown indication. The patient's past medical history included COVID-19 on 13-Jan-2022. Concurrent medical conditions included Obesity. On 24-Sep-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) .5 milliliter and dose of Influenza vaccine (Flu) (unknown route) 1 dosage form. On 24-Sep-2025, the patient experienced CHILLS (chills). On 25-Sep-2025, CHILLS (chills) had resolved. The concomitant medication was not reported by the reporter. The patient experienced chills 12 hours after the injection. The chills were mitigated with additional clothing. It was unknown if the patient experienced any additional symptoms or events. It was unknown if the patient had any additional medical history, concomitant disease or risk factor. There was no lab data or results available. The treatment medication was not reported by the reporter.
Obesity
Medical History/Concurrent Conditions: COVID-19